We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
-6.71%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$148M
AUM Growth
-$3.08M
Cap. Flow
+$15M
Cap. Flow %
10.15%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
2
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
NSTG
NanoString Technologies, Inc.
NSTG
+$20.1M
2
AKYA
Akoya BioSciences
AKYA
+$17.4M
3
GH icon
Guardant Health
GH
+$5.33M

Top Sells

Rank Stock Value
1
BRKR icon
Bruker
BRKR
+$11.4M
2
CTKB icon
Cytek Biosciences
CTKB
+$10.2M
3
MXCT icon
MaxCyte
MXCT
+$6.16M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
1
Natera
NTRA
$46.9B
$42.9M 28.95%
881,436
– –
AKYA
2
DELISTED
Akoya BioSciences
AKYA
$34.7M 23.43%
4,697,785
+2,600,000
+124% +$17.4M
GH icon
3
Guardant Health
GH
$21.9B
$24.2M 16.34%
676,047
+185,602
+38% +$5.33M
ADPT icon
4
Adaptive Biotechnologies
ADPT
$4.07B
$20.3M 13.72%
3,030,434
– –
NSTG
5
DELISTED
NanoString Technologies, Inc.
NSTG
$11M 7.45%
+2,726,891
New +$20.1M
MXCT icon
6
MaxCyte
MXCT
$143M
$8.65M 5.84%
1,885,000
-1,340,000
-42% -$6.16M
SONX
7
DELISTED
Sonendo, Inc.
SONX
$6.32M 4.26%
4,643,461
– –
BRKR icon
8
Bruker
BRKR
$8.94B
– –
-145,100
Closed -$11.4M
CTKB icon
9
Cytek Biosciences
CTKB
$611M
– –
-1,109,000
Closed -$10.2M

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Blue Water Life Science Advisors held 9 positions worth $148M, down 2% from $151M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Blue Water Life Science Advisors deployed $15M of net new capital in Q2 2023, opening 1 new position and adding to 2 existing holdings. Its largest new stake was NanoString Technologies, Inc.: 2,726,891 shares worth $11M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was MaxCyte, an estimated $6.16M trimmed.

  • Blue Water Life Science Advisors's largest Q2 2023 buy was NanoString Technologies, Inc.: 2,726,891 shares worth $11M.
  • Blue Water Life Science Advisors added most to Akoya BioSciences in Q2 2023, an estimated $17.4M increase.
  • Blue Water Life Science Advisors's biggest Q2 2023 reduction was MaxCyte, cutting an estimated $6.16M.
  • Blue Water Life Science Advisors fully exited Bruker in Q2 2023, selling an estimated $11.4M.
  • Blue Water Life Science Advisors's ten largest holdings make up 100% of its $148M portfolio in Q2 2023.
  • Blue Water Life Science Advisors opened 1 new position and closed 2 in Q2 2023.
  • Blue Water Life Science Advisors's portfolio value fell 2% quarter-over-quarter to $148M.

Based on Blue Water Life Science Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.